2017
DOI: 10.1161/jaha.117.005868
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST‐Segment Elevation Myocardial Infarction

Abstract: BackgroundPlaque erosion causes 30% of ST‐segment elevation myocardial infarctions, but the underlying cause is unknown. Inflammatory infiltrates are less abundant in erosion compared with rupture in autopsy studies. We hypothesized that erosion and rupture are associated with significant differences in intracoronary cytokines in vivo.Methods and ResultsForty ST‐segment elevation myocardial infarction patients with <6 hours of chest pain were classified as ruptured fibrous cap (RFC) or intact fibrous cap (IFC)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(20 citation statements)
references
References 31 publications
0
18
0
Order By: Relevance
“…Proteomic strategies applied to coronary arterial blood samples suggest distinct patterns of protein release in patients with ACS due to erosion versus rupture. 70 Beyond anti-platelet therapy, individuals with markers indicating substantive NETosis with ACS could undergo treatment with deoxyribonuclease (DNase) or inhibitors of PAD4. While these notions remain highly conjectural, they merit consideration as we strive to a more targeted treatment of individual segments of patients with ACS and have achieved success with current management strategies for ACS, rendering it unlikely that further intensification of management of traditional risk factors will yield increasing inroads into residual risk.…”
Section: Therapeutic and Clinical Implications Of Superficial Erosionmentioning
confidence: 99%
“…Proteomic strategies applied to coronary arterial blood samples suggest distinct patterns of protein release in patients with ACS due to erosion versus rupture. 70 Beyond anti-platelet therapy, individuals with markers indicating substantive NETosis with ACS could undergo treatment with deoxyribonuclease (DNase) or inhibitors of PAD4. While these notions remain highly conjectural, they merit consideration as we strive to a more targeted treatment of individual segments of patients with ACS and have achieved success with current management strategies for ACS, rendering it unlikely that further intensification of management of traditional risk factors will yield increasing inroads into residual risk.…”
Section: Therapeutic and Clinical Implications Of Superficial Erosionmentioning
confidence: 99%
“…Another potential thrombogenic fate of an atherosclerotic plaque is that of plaque erosion, in which a thrombus is formed in the absence of rupture, often with a disrupted endothelium and an enhanced proliferation of VSMCs (Virmani et al, 1999 ; Braunwald, 2013 ). Although less common than plaque rupture, plaque erosion has been shown to be more common in women and the elderly, while the underlying mechanisms of plaque erosion are only beginning to be elucidated and still incompletely understood (Libby and Pasterkamp, 2015 ; Chandran et al, 2017 ). Regardless of the etiology of the plaque source, the resulting thrombus formed by these processes may also embolize and travel to a secondary vessel causing ischemia, myocardial infarction, or sudden coronary death (Davies, 2000 ; Bentzon et al, 2014 ).…”
Section: Formation Of the Atherosclerotic Plaque: Local And Distant (mentioning
confidence: 99%
“…Yet, the need for OCT to discriminate between plaque rupture and erosion mandates a similar approach to their management in routine clinical practice. Further development of less invasive diagnostic biomarkers could advance the ability to distinguish these two aetiologies of ACS to guide more individualized treatment strategies [46].…”
Section: Discussionmentioning
confidence: 99%